Skip to main content
Premium Trial:

Request an Annual Quote

Gencove: Josh Mann

Gencove announced that Josh Mann has joined as chief commercial officer. He will be responsible for commercialization of Gencove's low-pass whole-genome sequencing software and service platform.

Mann comes to the firm from NeoGenomics Laboratories, where he was director of business development for informatics. He has also held executive roles at Sophia Genetics, TwinStrand Biosciences, and Meso Scale Diagnostics and spent eight years in sales at Qiagen.

Mann holds an MBA from the Julius Maximilians University of Würtzburg.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.